Architecture et Réactivité de l'ARN, CNRS UPR9002, Institut de Biologie Moléculaire et Cellulaire, Université de Strasbourg, France.
FEBS Open Bio. 2022 Sep;12(9):1584-1601. doi: 10.1002/2211-5463.13413. Epub 2022 Apr 25.
SARS-CoV-2 is a betacoronavirus that emerged in China in December 2019 and which is the causative agent of the Covid-19 pandemic. This enveloped virus contains a large positive-sense single-stranded RNA genome. In this review, we summarize the current knowledge on the molecular mechanisms for the translation of both viral transcripts and cellular messenger RNAs. Non-structural proteins are encoded by the genomic RNA and are produced in the early steps of infection. In contrast, the structural proteins are produced from subgenomic RNAs that are translated in the late phase of the infectious program. Non-structural protein 1 (NSP1) is a key molecule that regulates both viral and cellular translation. In addition, NSP1 interferes with multiple steps of the interferon I pathway and thereby blocks host antiviral responses. Therefore, NSP1 is a drug target of choice for the development of antiviral therapies.
SARS-CoV-2 是一种乙型冠状病毒,于 2019 年 12 月在中国出现,是导致 COVID-19 大流行的病原体。这种包膜病毒包含一个大型的正链单链 RNA 基因组。在这篇综述中,我们总结了目前关于翻译病毒转录本和细胞信使 RNA 的分子机制的知识。基因组 RNA 编码非结构蛋白,并在感染的早期阶段产生。相比之下,结构蛋白是由亚基因组 RNA 翻译产生的,该 RNA 在感染程序的晚期进行翻译。非结构蛋白 1(NSP1)是一种关键分子,它调节病毒和细胞的翻译。此外,NSP1 干扰干扰素 I 途径的多个步骤,从而阻止宿主抗病毒反应。因此,NSP1 是开发抗病毒疗法的首选药物靶点。